三个皮匠报告
首页
new
最新
合集
英文
会议
入驻
付费
数据
报告
报告 合集 数据

不同肿瘤类型中HER2过表达患者比例-行业数据

不同肿瘤类型中HER2过表达患者比例
不同肿瘤类型中HER2过表达患者比例
HER2是表皮生长因子受体家族的一种跨膜酪氨酸激酶受体，由于其胞外区结构的特殊性，需形成同源二聚体或与其它家族成员形成异源二聚体，才能激活下游信号通路。HER2 受体下游的信号传导途径主要包括 Ras-MAPK 和 PI3K-Akt 途径，前者通过调控有丝分裂，后者调控细胞的存活和凋亡进而加速癌症进展。
行业数据 下载Excel 下载图片 原图定位
图片属性
图片格式：PNG 图片大小：40KB 图片尺寸：1749*320
同报告图片
 / 28
不同肿瘤类型中HER2过表达患者比例_第1页
fCDogr/nmKTnsbvlnosgfCBCQyAgICB8IEdDICAgIHwgQ1JDICB8IE9DICAgIHwg6aOf6YGT55mMICB8IEVDICAgIHwgTlNDTEMgfAp8LS0tLS0tLS0tLXwtLS0tLS0tfC0tLS0tLS18LS0tLS0tfC0tLS0tLS18LS0tLS0tLS18LS0tLS0tLXwtLS0tLS0tfAp8IOi/h+ihqOi+vuaCo+iAheavlOS+iyUgfCAxNS0zMCB8IDEwLTMwIHwgMy01ICB8IDIwLTMwIHwgNy0yMiAgIHwgMTgtODAgfCAxMy0yMCB8CgrotYTmlpnmnaXmupDvvJrlhazlj7jmi5vogqHkuabvvIzlpKnpo47or4HliLjnoJTnqbbmiYA=
不同肿瘤类型中HER2过表达患者比例_第2页
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
不同肿瘤类型中HER2过表达患者比例_第3页
不同肿瘤类型中HER2过表达患者比例_第4页
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
不同肿瘤类型中HER2过表达患者比例_第5页
fCDlubTku70gfCBUcm9kZWxlduWFqOeQg+mUgOWUruaVsOaNru+8iOeZvuS4h+e+juWFg++8iSB8CnwgLS0tIHwgLS0tIHwKfCAyMDIwIHwgNDkgfAp8IDIwMjEgfCAzODAgfAp8IDIwMjIgfCA2ODAgfAp8IDIwMjMgfCAxMDYzIHwKfCAyMDI0UTEtUTMgfCA5NjAgfAoK6LWE5paZ5p2l5rqQ77ya5ZCJ5Yip5b636LSi5oql77yM5aSp6aOO6K+B5Yi456CU56m25omA
不同肿瘤类型中HER2过表达患者比例_第6页
不同肿瘤类型中HER2过表达患者比例_第7页
不同肿瘤类型中HER2过表达患者比例_第8页
不同肿瘤类型中HER2过表达患者比例_第9页
不同肿瘤类型中HER2过表达患者比例_第10页
不同肿瘤类型中HER2过表达患者比例_第11页
不同肿瘤类型中HER2过表达患者比例_第12页
不同肿瘤类型中HER2过表达患者比例_第13页
不同肿瘤类型中HER2过表达患者比例_第14页
不同肿瘤类型中HER2过表达患者比例_第15页
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
不同肿瘤类型中HER2过表达患者比例_第16页
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
不同肿瘤类型中HER2过表达患者比例_第17页
不同肿瘤类型中HER2过表达患者比例_第18页
不同肿瘤类型中HER2过表达患者比例_第19页
不同肿瘤类型中HER2过表达患者比例_第20页
fCDogr/nmKTnsbvlnosgfCBCQyAgICB8IEdDICAgIHwgQ1JDICB8IE9DICAgIHwg6aOf6YGT55mMICB8IEVDICAgIHwgTlNDTEMgfAp8LS0tLS0tLS0tLXwtLS0tLS0tfC0tLS0tLS18LS0tLS0tfC0tLS0tLS18LS0tLS0tLS18LS0tLS0tLXwtLS0tLS0tfAp8IOi/h+ihqOi+vuaCo+iAheavlOS+iyUgfCAxNS0zMCB8IDEwLTMwIHwgMy01ICB8IDIwLTMwIHwgNy0yMiAgIHwgMTgtODAgfCAxMy0yMCB8CgrotYTmlpnmnaXmupDvvJrlhazlj7jmi5vogqHkuabvvIzlpKnpo47or4HliLjnoJTnqbbmiYA=
不同肿瘤类型中HER2过表达患者比例_第21页
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
不同肿瘤类型中HER2过表达患者比例_第22页
不同肿瘤类型中HER2过表达患者比例_第23页
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
不同肿瘤类型中HER2过表达患者比例_第24页
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
不同肿瘤类型中HER2过表达患者比例_第25页
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
不同肿瘤类型中HER2过表达患者比例_第26页
不同肿瘤类型中HER2过表达患者比例_第27页
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
不同肿瘤类型中HER2过表达患者比例_第28页
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
不同肿瘤类型中HER2过表达患者比例_第29页
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
所属报告： 科伦博泰生物-公司研究报告：ADC平台技术优势突出核心品种TROP2 ADC获批上市-241208（32页）.pdf
打包全文图表

相关数据

最新数据
联系我们
  • 0731-84720580
  • sgpjbg002
  • 工作日 9:30 - 18:00
关于我们
侵权处理
关于我们

三个皮匠报告专业的行业报告下载站，每日更新，欢迎大家关注！

copyright@2008-2013 长沙景略智创信息技术有限公司版权所有
网站备案/许可证号：湘B2-20190120

客服
商务合作
小程序
服务号